Skip to main content

Table 4 Parameter wise number of patients who scored less than the best possible grade (<BPG) at baseline and reached BPG afterwards

From: Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy

Parameters Affected patients (<BPG) Improved patients at end of therapy; n (%)
Appetite 7 7 (100.0)
Attention 3 3 (100.0)
Balance—eyes closed in straight line 26 1 (3.8)
Balance—eyes open in straight line 24 3 (12.5)
Bladder—control 12 2 (16.7)
Bladder—sensation 8 2 (25.0)
Bowel—control 6 1 (16.7)
Bowel—sensation 4 2 (50.0)
Breathing pattern—Brady 1 1 (100.0)
Communication—speech 4 2 (50.0)
Coordination 14 0
Deformity 8 1 (12.5)
Depression 6 4 (66.7)
Double-vision + color blindness 5 1 (20.0)
Ears—hearing 3 3 (100.0)
Eye pain 2 2 (100.0)
Fatigue 22 8 (36.4)
Floaters 2 1 (50.0)
Irritability 7 4 (57.1)
Language 3 1 (33.3)
Limb tremors 15 6 (40.0)
Memory 7 5 (71.4)
Muscle weakness 27 3 (11.1)
Myalgia 11 5 (45.5)
Orientation—yes or no 1 1 (100.0)
Pain 18 7 (38.9)
Paralysis 5 0
Paraesthesia 11 5 (45.5)
Physical—drooling 1 1 (100.0)
Sitting 18 5 (27.8)
Sleep disorder—hypersomnia 4 4 (100.0)
Sleep disorder—hyposomnia 3 2 (66.7)
Stiffness 19 10 (52.6)
Tingling 7 3 (42.9)
Tinnitus 3 3 (100.0)
Vision—blurring 11 3 (27.3)
  1. BPG best possible grade